NCT03613116View on ClinicalTrials.gov

High-dose Vitamin D Supplements in Older Adults

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

March 18, 2019

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Vitamin D DeficiencyCognitive Decline
Interventions
DIETARY_SUPPLEMENT

Vitamin D3

One-half of each diagnostic group will be randomized to treatment with high-dose vitamin D3 or to standard dose Vitamin D

Trial Locations (1)

94598

University of California, Davis Alzheimer's Disease Center, Walnut Creek

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute on Aging (NIA)

NIH

lead

University of California, Davis

OTHER

NCT03613116 - High-dose Vitamin D Supplements in Older Adults | Biotech Hunter | Biotech Hunter